Milestone Scientific Inc.
MLSS · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 1.6% | 4.1% | 10.9% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 68.7% | 69.6% | 73.8% | 75% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $3 | $3 | $0 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $4 | $4 |
| Operating Income | -$1 | -$1 | -$2 | -$2 |
| % Margin | -48.1% | -63.9% | -89.5% | -101.4% |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | -$1 | -$1 | -$2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$2 | -$2 |
| % Margin | -48.9% | -63.8% | -89.3% | -101.1% |
| EPS | -0.01 | -0.018 | -0.024 | -0.026 |
| % Growth | 44.8% | 25.8% | 4.3% | – |
| EPS Diluted | -0.01 | -0.018 | -0.024 | -0.026 |
| Weighted Avg Shares Out | 82 | 82 | 82 | 80 |
| Weighted Avg Shares Out Dil | 82 | 82 | 82 | 80 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$2 | -$2 |
| % Margin | -46.4% | -61.7% | -87.5% | -99.7% |